Latest Oncology Stories
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
VANCOUVER, Canada and HOUSTON, TX, March 2, 2015 /PRNewswire/ - ESSA Pharma Inc.
New system for fast, precise radiotherapy and radiosurgery now ready for clinical use SINGAPORE, March 2, 2015 /PRNewswire/ -- Mount Elizabeth Novena Hospital will soon become the
CALGARY, March 2, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
A long-term study of sheet metal workers suggests that many are at risk for asbestos-related diseases like mesothelioma and asbestosis, even though they may not work directly with asbestos.
The Mesothelioma Applied Research Foundation will honor its awards recipients during its annual Awards Dinner, on Monday, March 2 for their hard work in the mission to cure mesothelioma.
The Mesothelioma Applied Research Foundation (Meso Foundation) will broadcast live, free of charge, its Symposium sessions on Tuesday, March 3, starting at 9:30 AM Eastern Time. Bethesda,
The Oncology Institute of Hope and Innovation announces the opening of the following clinical trial that may benefit some prostate cancer patients. Downey, CA
Former NASA Commander Tom Henricks to Give Keynote Address at 8th Annual Interdisciplinary Prostate Cancer Congress® Developed by Physicians’ Education Resource® PLAINSBORO,
On March 2-4, the Mesothelioma Applied Research Foundation and the National Cancer Institute (NCI) will co-host the annual International Symposium on Malignant Mesothelioma at the National Institutes
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.